UPMC Enterprises

Activity from announced rounds

Activity in this selectionFeb 28, 2026 · Feb 1, 2026

UPMC Enterprises is the organization identified in its own RAAPID, BrainCheck and ai3Bio materials.

Recorded funding activity

RAAPID supplies healthcare risk-adjustment software. Ai3Bio develops immune-cell-targeted medicines. The pending ai3Bio relation stays in draft, and the organization remains separate from UPMC and the University of Pittsburgh.

Sources
Rounds participated in
1
Confirmed lead rounds
—
1 roles undisclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$13M
1 disclosed · full round size, not this investor’s share

By stage

Series A1

By primary sector

Healthtech1

By country

United States1

Rounds

1 in this selection
BrainCheck

Provides digital cognitive assessment and care for healthcare organizations

$13MSeries A
Role not disclosed